封面
市场调查报告书
商品编码
1410797

全球大肠镜市场 - 市场规模(按细分市场)、份额、监管、报销、程序、运行设备数量、预测(截至 2033 年)

Colonoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

在大肠镜市场,从非视讯柔性大肠镜到视讯柔性大肠镜的转变预计将继续。 随着老年人口的增加和大肠癌的盛行率,预计市场将在预测期内扩大。

本报告研究和分析了全球大肠镜检查市场,并提供了有关每个细分市场的市场规模、市场趋势、竞争状况以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

市售大肠镜与不断变化的竞争格局

  • 对主要产业趋势的考虑
  • 按大肠镜检查市场细分的年收入和市场前景(2015-2033 年)
  • 按细分市场划分的总营业量、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

  • 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
  • 大肠镜检查市场的SWOT分析
  • 大肠镜检查市场竞争动态的考量与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息,使您能够更深入地研究市场动态。

  • 各国医疗保健系统概览
  • 按国家/地区划分的报销政策
  • 各国医疗科技监理状况

目标公司

  • Olympus Corp
  • Fujifilm Holdings Corp
  • Hoya Corp
  • KARL STORZ SE & Co KG
  • SonoScape Medical Corp
  • Boston Scientific Corp
  • SMART Medical Systems Ltd
  • 其他

Abstract

Colonoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on the Colonoscopes market for the year 2020 and beyond. Colorectal cancer is a major public health issue in both developing and developed countries, however, methods for diagnosis have improved dramatically with advanced colonoscopy technologies. The colonoscope market is expected to continue transitioning from flexible non-video to flexible video colonoscopes. With the rise in aging populations and the increasing prevalence of colorectal cancer, GlobalData expects the colonoscopes market to increase throughout the forecast period.

Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive Excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Colonoscopes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Colonoscopes market revenue by segment and market outlooks from 2015-2033.
  • Granular data on the total installed base, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Colonoscopes market.
  • Competitive dynamics insights and trends provided for the Colonoscopes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Olympus Corp, Fujifilm Holdings Corp, Hoya Corp, KARL STORZ SE & Co KG, SonoScape Medical Corp, Boston Scientific Corp, SMART Medical Systems Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Colonoscopes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Colonoscopes market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Colonoscopes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Colonoscopes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Colonoscopes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable